These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 1455306)

  • 1. A randomized, prospective trial of postoperative somatostatin analogue in patients with neuroendocrine tumors of the pancreas.
    Lange JR; Steinberg SM; Doherty GM; Langstein HN; White DE; Shawker TH; Eastman RC; Jensen RT; Norton JA
    Surgery; 1992 Dec; 112(6):1033-7; discussion 1037-8. PubMed ID: 1455306
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The use of low dose octreotide prophylaxis in pancreatic transplants with enteric drainage. Results of a prospective randomized single center trial.
    Hesse UJ; Meester D; Troisi R; Cathenis K; Lameire N; Hemptinne B
    Clin Transplant; 2005 Jun; 19(3):299-303. PubMed ID: 15877788
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of somatostatin and its analogues in pancreatic surgery and pancreatic disorders.
    Friess H; Büchler MW
    Digestion; 1996; 57 Suppl 1():97-102. PubMed ID: 8813484
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevention of postoperative complications following pancreatic surgery.
    Büchler M; Friess H
    Digestion; 1993; 54 Suppl 1():41-6. PubMed ID: 8103013
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of octreotide in the prevention of postoperative complications following pancreatic resection.
    Büchler M; Friess H; Klempa I; Hermanek P; Sulkowski U; Becker H; Schafmayer A; Baca I; Lorenz D; Meister R
    Am J Surg; 1992 Jan; 163(1):125-30; discussion 130-1. PubMed ID: 1733360
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of intra-arterial octreotide on pancreatic texture: a randomized controlled trial.
    Belyaev O; Polle C; Herzog T; Munding J; Chromik AM; Meurer K; Tannapfel A; Bergmann U; Müller CA; Uhl W
    Scand J Surg; 2013; 102(3):164-70. PubMed ID: 23963030
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of pancreatic secretion to prevent postoperative complications following pancreatic resection.
    Büchler M; Friess H
    Acta Gastroenterol Belg; 1993; 56(3-4):271-8. PubMed ID: 8266770
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Octreotide inhibits pancreatic exocrine secretion and prevents pancreatoenterostomy leakage.
    Nakatsuka A; Yamaguchi K; Chijiiwa K; Tanaka M
    Int Surg; 2000; 85(2):124-9. PubMed ID: 11071328
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prophylaxis of complications after pancreatic surgery: results of a multicenter trial in Germany.
    Fiess H; Klempa I; Hermanek P; Sulkowski U; Uhl W; Beger HG; Büchler MW
    Digestion; 1994; 55 Suppl 1():35-40. PubMed ID: 8132135
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Octreotide prophylaxis is not beneficial for biochemical activity and clinical severity of postoperative pancreatic fistula after pancreatic surgery.
    Droeser RA; Jeanmonod P; Schuld J; Moussavian MR; Schilling MK; Kollmar O
    Dig Surg; 2012; 29(6):484-91. PubMed ID: 23392293
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 111In-octreotide scintigraphy: a tool to select patients with endocrine pancreatic tumors for octreotide treatment?
    Keymeulen B; Bossuyt A; Peeters TL; Somers G
    Ann Nucl Med; 1995 Aug; 9(3):149-52. PubMed ID: 8534589
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is octreotide beneficial following pancreatic injury?
    Nwariaku FE; Terracina A; Mileski WJ; Minei JP; Carrico CJ
    Am J Surg; 1995 Dec; 170(6):582-5. PubMed ID: 7492005
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety and efficacy of early drain removal and triple-drug therapy to prevent pancreatic fistula after distal pancreatectomy.
    Adachi T; Kuroki T; Kitasato A; Hirabaru M; Matsushima H; Soyama A; Hidaka M; Takatsuki M; Eguchi S
    Pancreatology; 2015; 15(4):411-6. PubMed ID: 26073457
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Octreotide and postoperative enterocutaneous fistulae: a controlled prospective study.
    Scott NA; Finnegan S; Irving MH
    Acta Gastroenterol Belg; 1993; 56(3-4):266-70. PubMed ID: 8266769
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dosimetry and biodistribution of an iodine-123-labeled somatostatin analog in patients with neuroendocrine tumors.
    O'Connor MK; Kvols LK; Brown ML; Hung JC; Hayostek RJ; Cho DS; Vetter RJ
    J Nucl Med; 1992 Sep; 33(9):1613-9. PubMed ID: 1517834
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prophylaxis of complications after pancreatic surgery: results of a multicenter trial in Italy. Italian Study Group.
    Bassi C; Falconi M; Lombardi D; Briani G; Vesentini S; Camboni MG; Pederzoli P
    Digestion; 1994; 55 Suppl 1():41-7. PubMed ID: 8132136
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Prospective and randomized study on the usefulness of octreotide in the prevention of complications after cephalic duodeno-pancreatectomy].
    Briceño Delgado FJ; López Cillero P; Rufián Peña S; Solórzano Peck G; Miño Fugarolas G; Pera Madrazo C
    Rev Esp Enferm Dig; 1998 Oct; 90(10):687-94. PubMed ID: 9824933
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pancreatic resection: drain or no drain?
    Adham M; Chopin-Laly X; Lepilliez V; Gincul R; Valette PJ; Ponchon T
    Surgery; 2013 Nov; 154(5):1069-77. PubMed ID: 23876363
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Octreotide in the treatment of thoracic duct injuries.
    Markham KM; Glover JL; Welsh RJ; Lucas RJ; Bendick PJ
    Am Surg; 2000 Dec; 66(12):1165-7. PubMed ID: 11149591
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Randomized controlled trial comparing somatostatin with octreotide in the prevention of complications after pancreatectomy.
    Closset J; Journe S; Mboti F; El Nakadi I; Gelin M
    Hepatogastroenterology; 2008; 55(86-87):1818-23. PubMed ID: 19102400
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.